Cosmo Pharmaceuticals N.V. (FRA:C43)

Germany flag Germany · Delayed Price · Currency is EUR
131.00
-4.00 (-2.96%)
At close: Feb 20, 2026
Market Cap2.08B +93.9%
Revenue (ttm)182.27M -1.7%
Net Income59.99M +1.7%
EPS3.67 +0.1%
Shares Outn/a
PE Ratio34.67
Forward PE446.08
Dividend2.05 (1.52%)
Ex-Dividend DateJun 4, 2025
Volume163
Average Volume427
Open135.00
Previous Close135.00
Day's Range130.00 - 135.00
52-Week Range47.80 - 141.00
Betan/a
RSI58.06
Earnings DateMar 9, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 332
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements